University of Kentucky

UKnowledge
Superfund Research Center Faculty
Publications

Superfund Research Center

4-1-2017

A Compromised Liver Alters Polychlorinated Biphenyl-Mediated
Toxicity
Banrida Wahlang
University of Kentucky

Jordan T. Perkins
University of Kentucky

Michael C. Petriello
University of Kentucky, michaelcpetriello@gmail.com

Jessie B. Hoffman
University of Kentucky, jessie.hoffman@uky.edu

Arnold J. Stromberg
University of Kentucky, stromberg@uky.edu

See next page for additional authors
Follow this and additional works at: https://uknowledge.uky.edu/superfund_facpub
Part of the Environmental Health and Protection Commons, and the Toxicology Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Wahlang, Banrida; Perkins, Jordan T.; Petriello, Michael C.; Hoffman, Jessie B.; Stromberg, Arnold J.; and
Hennig, Bernhard, "A Compromised Liver Alters Polychlorinated Biphenyl-Mediated Toxicity" (2017).
Superfund Research Center Faculty Publications. 7.
https://uknowledge.uky.edu/superfund_facpub/7

This Article is brought to you for free and open access by the Superfund Research Center at UKnowledge. It has
been accepted for inclusion in Superfund Research Center Faculty Publications by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

A Compromised Liver Alters Polychlorinated Biphenyl-Mediated Toxicity
Digital Object Identifier (DOI)
https://doi.org/10.1016/j.tox.2017.02.001

Notes/Citation Information
Published in Toxicology, v. 380, p. 11-22.
© 2017 Elsevier B.V. All rights reserved.
This manuscript version is made available under the CC‐BY‐NC‐ND 4.0 license
https://creativecommons.org/licenses/by-nc-nd/4.0/.
The document available for download is the author's post-peer-review final draft of the article.

Authors
Banrida Wahlang, Jordan T. Perkins, Michael C. Petriello, Jessie B. Hoffman, Arnold J. Stromberg, and
Bernhard Hennig

This article is available at UKnowledge: https://uknowledge.uky.edu/superfund_facpub/7

HHS Public Access
Author manuscript
Author Manuscript

Toxicology. Author manuscript; available in PMC 2018 April 01.
Published in final edited form as:
Toxicology. 2017 April 01; 380: 11–22. doi:10.1016/j.tox.2017.02.001.

A Compromised Liver Alters Polychlorinated Biphenyl-Mediated
Toxicity
Banrida Wahlanga,b, Jordan T. Perkinsa, Michael C. Petrielloa,b, Jessie B. Hoffmana,c,
Arnold J. Stromberga,d, and Bernhard Henniga,b,c,*
aSuperfund

Research Center, University of Kentucky, Lexington, KY, USA 40536

Author Manuscript

bDepartment

of Animal and Food Sciences, College of Agriculture, Food, and Environment,
University of Kentucky, Lexington, KY, USA 40536

cGraduate

Center for Nutritional Sciences, College of Medicine, University of Kentucky, Lexington,

KY 40536
dDepartment

of Statistics, College of Arts and Sciences, University of Kentucky, Lexington, KY,

USA 40536

Abstract
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Exposure to environmental toxicants namely polychlorinated biphenyls (PCBs) is correlated with
multiple health disorders including liver and cardiovascular diseases. The liver is important for
both xenobiotic and endobiotic metabolism. However, the responses of an injured liver to
subsequent environmental insults has not been investigated. The current study aims to evaluate the
role of a compromised liver in PCB-induced toxicity and define the implications on overall body
homeostasis. Male C57Bl/6 mice were fed either an amino acid control diet (CD) or a methioninecholine deficient diet (MCD) during the 12-week study. Mice were subsequently exposed to either
PCB126 (4.9 mg/kg) or the PCB mixture, Arcolor1260 (20 mg/kg) and analyzed for inflammatory,
calorimetry and metabolic parameters. Consistent with the literature, MCD diet-fed mice
demonstrated steatosis, indicative of a compromised liver. Mice fed the MCD-diet and
subsequently exposed to PCB126 showed observable wasting syndrome leading to mortality.
PCB126 and Aroclor1260 exposure worsened hepatic fibrosis exhibited by the MCD groups.
Interestingly, PCB126 but not Aroclor1260 induced steatosis and inflammation in CD-fed mice.
Mice with liver injury and subsequently exposed to PCBs also manifested metabolic disturbances
due to alterations in hepatic gene expression. Furthermore, PCB exposure in MCD-fed mice led to
extra-hepatic toxicity such as upregulated circulating inflammatory biomarkers, implicating
endothelial cell dysfunction. Taken together, these results indicate that environmental pollution can
exacerbate toxicity caused by diet-induced liver injury which may be partially due to dysfunctional
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energy homeostasis. This is relevant to PCB-exposed human cohorts who suffer from alcohol or
diet-induced fatty liver diseases.

Graphical abstract
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1. Introduction
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Polychlorinated biphenyls (PCBs) are synthetic organochlorine compounds that were
manufactured over three decades ago and used as dielectric fluids in electrical equipment.
The global production of PCBs is estimated at 1.5 million tons with the United States being
the single largest producer. PCB production in the United States was banned by the United
States Congress in 1979 and worldwide in 2001 by the Stockholm Convention on Persistent
Organic Pollutants (Xu et al. 2013). Despite being banned for over 30 years, the chemical
and thermodynamic stability of PCBs allowed them to resist degradation and hence they still
persist in the ecosystem. Exposure to persistent organic pollutants such as PCBs is positively
correlated with increased risk of developing multiple diseased outcomes such as liver
disease, hypertension, diabetes and vascular diseases (Cave et al. 2010; Perkins et al. 2016;
Taylor et al. 2013). Based on their chemical structure, PCBs can be classified as either
coplanar or non-coplanar. The coplanar PCBs are mostly the lower-chlorinated congeners
that have less than one-ortho chlorine substitution in their phenyl ring while the noncoplanar ones have more than one-ortho substitutions and usually comprise of the higher
chlorinated congeners. Furthermore, based on the structure of the specific congener, PCBs
have also been proposed to bind and/or activate different receptors in the body, eventually
leading to different pathological outcomes (Wahlang et al. 2014a). Animal studies have
shown that coplanar PCB exposure is mostly associated with vascular cell dysfunction and
inflammation (Petriello et al. 2014) while exposure to higher chlorinated, non-coplanar
PCBs is associated with obesity and fatty liver disease (Wahlang et al. 2013; Wahlang et al.
2014b). Humans are exposed to multiple PCB congeners especially the heavily-chlorinated
ones that are more resistant to degradation and thus, tend to persist in the ecosystem.
Therefore, in the context of the human exposure paradigm, the presence of both classes of
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PCBs in the body may result in more complex health outcomes by affecting different organ
systems.
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The liver, being the primary site for xenobiotic detoxification, is the principal target organ
for toxic effects induced by environmental pollutants including PCBs. However, the liver
possesses additional functions such as maintaining energy homeostasis in the body attributed
to its role in endobiotic metabolism (Rui 2014). Liver injury and liver diseases such as nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have been
linked to other health complications such as obesity, diabetes, insulin resistance and the
metabolic syndrome (Firneisz 2014). Moreover, liver disease has been considered to be a
risk factor for other disorders such as cardiovascular diseases (Bhatia et al. 2012; Magida
and Leinwand 2014; Naschitz et al. 2000). In fact, NAFLD occurs worldwide and it is the
most common form of liver disease in industrialized countries. In the United States, NAFLD
accounts for 75% of chronic liver diseases and affects all ages (Hassan et al. 2014).
Moreover, the liver is the site for PCB metabolism and any injury to the liver may
compromise the ability of the body to metabolize and excrete these compounds, which could
result in more deleterious effects exerted by the parent compound. Therefore, it is important
to evaluate the effects of chemicals such a PCBs on a compromised liver and to determine if
this would disrupt normal energy metabolism. This will allow us to better understand how
crucial and relevant is the liver’s role in mitigating the toxic effects of environmental
pollutants. Furthermore, it will also identify interactions between the heart and extra-hepatic
organ systems that may act cumulatively in exacerbating PCB toxicity and other health
complications such as obesity and the metabolic syndrome.

Author Manuscript

In the current study, we aim to investigate the effects of PCB exposure in the presence of a
compromised liver and evaluated hepatic and peripheral (extra-hepatic) toxicity endpoints.
In order to test our hypothesis, mice were fed a methionine-choline deficient (MCD) diet to
induce hepatic fibrosis and injury (Liu et al. 2013). Mice were then exposed to PCBs, either
as a single congener (PCB126) or a mixture of congeners, using the commercial PCB
mixture, Aroclor1260. The results obtained from the study demonstrated that the liver is
indeed crucial for maintenance of energy homeostasis in the body and that exposure of a
compromised liver to different PCB congeners can consequently lead to severe toxicological
outcomes.

2. Materials and methods
2.1. Animals, diets and PCB exposure

Author Manuscript

The animal protocol was approved by the University of Kentucky Institutional Animal Care
and Use Committee. Eight week-old wild type male C57Bl/6 mice were purchased form
Taconic (Hudson, NY, USA). Mice were divided into 6 study groups (n=10) based on either
diet type, PCB126 exposure or Aroclor1260 exposure during this 12-week study utilizing a
2×3 design. Mice were housed in a temperature- and light controlled-room (12 hour light; 12
hour dark) with food and water ad libitum. For the first two weeks, all animals received the
amino acid control diet (CD; TD.94149; Harlan Teklad, Madison, WI, USA). Diet
components are described in Supplementary Table 1. The groups designed to receive the
methionine-choline deficient (MCD) diet were fed with the MCD diet (TD.90262, Harlan
Toxicology. Author manuscript; available in PMC 2018 April 01.
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Teklad) from week 3 onwards. On week 6–7 and week 8–9, the MCD-fed mice were
restored back to CD- feeding because of the excess weight loss that was non-compliant with
the IACUC protocol. PCB126 or Aroclor1260 (both purchased from AccuStandard, CT,
USA) was administered in corn oil by oral gavage (vs. corn oil alone). PCB126 (2.45 mg/kg)
and Aroclor1260 (10 mg/kg) were gavaged in two individualized doses on week 5 and week
7 to minimize acute toxicity, resulting in a cumulative dosage of 4.9 mg/kg for PCB126 and
20 mg/kg for Aroclor1260. The dosages selected were based on previous PCB studies
(Newsome et al. 2014; Wahlang et al. 2016; Wahlang et al. 2014b) where PCB126 has been
shown to induce inflammation in mouse models while Aroclor1260 resembled PCB levels
found in a PCB-exposed human cohort. The different groups based on diet and exposure
timelines are shown in Supplementary Fig. 1. After the second gavage was administered
(week 7), some of the mice from the MCD+PCB126 group died (n=3). The rest of the mice
were extremely sick and lethargic, and their body weight was under the weight limit required
by the IACUC protocol (>20% loss in body weight), hence they were subsequently
euthanized at the end of week 8. Due to their extremely low bodyweight, only their livers
were collected for hepatic analysis. A glucose tolerance test was performed at week 10.
During weeks 11–12, 5 mice were randomly selected from each group and placed in
metabolic chambers (PhenoMaster, TSE systems, Chesterfield, MO, USA) overnight to
assess food/water consumption and physical activity. Animals were euthanized (ketamine/
xylazine, 100/20 mg/kg body weight, i.p.) at the end of week 12. Prior to euthanasia, the
animals were analyzed for lean and body fat composition using the EchoMRI (EchoMRI
LLC, Houston, TX, USA). Ethylenediaminetetraacetic acid was added to collected blood
samples, briefly mixed, and centrifuged at 2000 g for 15 min at 4 °C to separate blood
plasma. Plasma samples were frozen in liquid nitrogen and stored at −80 °C until
processing. Tissues were harvested for mRNA or protein and stored at −80 °C prior to
analysis. Thus, six different groups were evaluated; CD+vehicle, CD+PCB126, CD
+Aroclor1260, MCD+vehicle, MCD+PCB126, MCD+Aroclor1260.
2.2. Ultrasound imaging and blood pressure measurements

Author Manuscript

On week 8, 2 mice were randomly chosen from each group and high-frequency ultrasound
imaging was performed using the Vevo 2100 Imaging System (VisualSonics Inc., Toronto,
Ontario, Canada) to determine the development/extent of liver steatosis and fibrosis
(Fernandez-Dominguez et al. 2011). During imaging sessions, mice were kept under
anesthesia using 1.5% isoflurane in oxygen and restrained on a heated stage. The mouse
abdomen was depilated with commercial hair removal cream (Veet, Reckitt Benckifer,
Granollers, Spain), and an ultrasound coupling gel was applied to the depilated skin. Images
of the liver were acquired through the ventral body wall in transverse and sagittal
orientations, employing a 40-MHz probe. Systolic and diastolic blood pressure
measurements were measured using a non-invasive tail-cuff system (Coda 8; Kent Scientific
Corporation, Torrington, CT, USA). The measurements were performed for four sequential
days on week 11 of the study.
2.3. Glucose tolerance test
On the day of the test, mice were fasted for 6 h (6 a.m.–12 p.m.), and fasting blood glucose
levels were measured with a hand-held glucometer (ACCU-CHECK Aviva, Roche, Basel,
Toxicology. Author manuscript; available in PMC 2018 April 01.
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Switzerland) using 1–2 μL blood via tail snip. Glucose was then administered (1 mg
glucose/g body weight, sterile saline, i.p.), and blood glucose was measured at 5, 15, 30, 60,
90 and 120 min post injection. Diabetic parameters including insulin resistance and insulin
sensitivity were assessed. Insulin resistance was calculated by the homeostasis model
assessment using the formula: homeostasis model assessment of insulin resistance (HOMAIR) =fasting glucose (mg/dL) × fasting insulin (μU/mL)/405. Insulin sensitivity was assessed
using the quantitative insulin sensitivity check index (QUICKI) as follows: QUICKI=1/[log
(fasting insulin) + log (fasting glucose)], and HOMA-β= [(360 × fasting insulin)/(fasting
glucose−63)] %.
2.4. Histological studies

Author Manuscript

Sections from the liver and adipose tissue were fixed in 10% neutral buffered formalin and
embedded in paraffin for routine histological examination. Tissue sections were stained with
hematoxylin-eosin (H&E) or for chloroacetate esterase activity [CAE, Naphthol AS-D
Chloroacetate (Specific Esterase) Kit, Sigma Aldrich, St. Louis, MO, USA] and examined
by light microscopy. Photomicrographic images were captured using a high-resolution
digital scanner at 10x and 40x magnification.
2.5. Cytokine and adipokine measurement

Author Manuscript

The Milliplex Map Mouse Adipokine Magnetic Bead Panel (Millipore Corp, Billerica, MA,
USA) was utilized to measure plasma cytokines (tumor necrosis factor alpha (Tnfα),
interleukin-6 (IL-6), macrophage chemoattractant protein-1 (Mcp-1)), insulin, adipokines
(leptin, resistin), and plasminogen activator inhibitor-1 (PAI-1); while the Milliplex Map
Mouse CVD Magnetic Bead Panel 1 was used to measure plasma CVD markers on the
Luminex Xmap MAGPIX system (Luminex Corp, Austin, TX, USA), as per the
manufacturer’s instructions.
2.6. Real-time PCR

Author Manuscript

Mouse liver samples were homogenized and total RNA was extracted using the TRIzol
reagent (Thermo Fisher Scientific Inc, Waltham, MA, USA). RNA purity and quantity were
assessed with the NanoDrop 2000/2000c (Thermo Fisher Scientific Inc) using the NanoDrop
2000 (Installation Version 1.6.198) software. cDNA was synthesized from total RNA using
the QuantiTect Reverse Transcription Kit (Qiagen, Valencia, CA, USA). Polymerase chain
reaction (PCR) was performed on the CFX96 Touch Real-Time PCR Detection System
(Bio-Rad, Hercules, CA, USA) using the Taqman Fast Advanced Master Mix (Thermo
Fisher Scientific Inc). Primer sequences from Taqman Gene Expression Assays (Thermo
Fisher Scientific Inc) were as follows: tumor necrosis factor alpha (Tnfα);
(Mm00443258_m1), plasminogen activator inhibitor (PAI-1, serpine 1);
(Mm00435858_m1), tissue inhibitor of metalloproteinase 1 (Timp-1); (Mm01341361_m1),
(NAD(P)H dehydrogenase, quinone 1 (Nqo1); (Mm01253561_m1), heme oxygenase 1
(Hmox1); (Mm00516005_m1), fatty acid synthase (Fas); (Mm00662319_m1), peroxisome
proliferator-activated receptor alpha (Pparα); (Mm00440939_m1), carnitine palmitoyl
transferase 1A (Cpt1a); (Mm01231183_m1), phosphoenolpyruvate carboxykinase 1
(Pepck-1); (Mm01247058_m1), glucose-6-phosphatase (G6Pase); (Mm00839363_m1),
cytochrome P450s [Cyp2b10 (Mm01972453_s1), Cyp3a11 (Mm00731567_m1), Cyp1a2
Toxicology. Author manuscript; available in PMC 2018 April 01.
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(Mm00487224_m1)], flavin containing monooxygenase 3 (Fmo3); (Mm01306345_m1),
cluster of differentiation 36 (Cd36) (Mm01135198_m1), beta actin (Actb);
(Mm02619580_g1), natriuretic peptide type A (ANF, Nppa); (Mm01255748_g1), fibroblast
growth factor 21 (Fgf21); (Mm00840165_g1), and peptidylprolyl isomerase A (Ppia);
(Mm02342430_g1). The levels of mRNA were normalized relative to the amount of Actb
and Ppia mRNA for liver and heart respectively, and expression levels in mice fed control
diet and administered vehicle were set at 1. Gene expression levels were calculated
according to the 2−ΔΔCt method (Livak and Schmittgen 2001).
2.7. Statistical Analysis

Author Manuscript

Statistical analyses were performed using the JMP statistical software version 12.0 (SAS
Institute Inc., Cary, NC). Graphs were plotted using GraphPad Prism version 6.07 for
Windows (GraphPad Software Inc., La Jolla, CA, USA). Data are expressed as mean ±
SEM. For 2 group comparison, an unpaired t-test was used. Multiple group data were
compared using One Way ANOVA followed by Tukey’s post-hoc test while interactions
between diet and either PCB126 or Aroclor1260 exposure were calculated using the Fit
Least Square Model. P <0.05 was considered statistically significant. All statistical analyses
were overseen by biostatisticians at the University of Kentucky.

Results
3.1. PCB exposure exacerbated liver injury induced by the MCD diet

Author Manuscript

The MCD-fed groups developed steatosis and potentially hepatic fibrosis by week 8 of the
study as determined by non-invasive, ultrasound imaging (Supplementary Fig. 2). Overall,
the CD-fed mice showed homogeneous liver parenchyma and regular liver surface.
Echogenicity which is the ability of the surface to bounce back an echo or signal and reflects
the degree of steatosis and fibrosis was also determined. The MCD-fed mice appeared to
have irregular liver surfaces and increased echogenicity. The liver surface also showed
hyperechoic areas vs. the CD groups, indicating fatty infiltration. Body composition analysis
revealed that the MCD groups had a higher lean mass composition than the CD groups while
they had a lower body fat composition as well (Supplementary Fig. 3).

Author Manuscript

Hepatic steatosis was assessed histologically while hepatic inflammation was assessed by
liver weight, histology, serum cytokine and hepatic gene expression measurements. All
MCD groups exhibited steatosis (H&E staining) consistent with previous reports.
Interestingly, PCB126 induced steatosis in the CD-fed mice but this was absent in the
Aroclor1260-exposed mice (Fig. 1A). Body weight was measured throughout the 12-week
study for 5 of the 6 groups and for 8 weeks for the MCD+PCB126 group. PCB126 and
Aroclor1260 exposure decreased bodyweight in the MCD groups (Fig. 1B). There was a
significant interaction between PCB126 and the MCD diet (p=0.0219) resulting in
exacerbated weight loss. During the study, PCB126 induced mortality (n=3) in the MCD-fed
mice on Week 7. The rest of the mice displayed signs of wasting, lethargy, and >20% loss in
body weight, therefore they were subsequently euthanized on week 8. Hence the MCD
+PCB126 group was absent in most experimental analysis. The liver weight to body weight
(LW/BW) ratio was calculated and all the MCD-fed mice developed steatosis by the end of
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the study (Fig. 1C). However, the LW/BW was greatest in the MCD+PCB126 group
(significant interaction, p=0.001).

Author Manuscript

Scattered inflammatory foci with neutrophil infiltration were observed on CAE stained liver
sections for all the MCD groups while the PCB126-exposed mice showed signs of hepatic
inflammation in the CD groups (Fig. 2A). Hepatic Tnfα expression was significantly
increased in all the MCD-fed mice while only the PCB126-exposed mice showed increased
hepatic Tnfα among the CD-fed groups (Fig. 2B). Hepatic expression of fibrotic markers
including PAI-1 and Timp-1 were also measured (Fig. 2C & D). PCB126 increased hepatic
PAI-1 and Timp-1 mRNA levels irrespective of the diet type given while Aroclor1260
exposure slightly increased PAI-1 levels in the MCD group. MCD diet feeding also
increased the hepatic expression of Timp-1. Circulating PAI-1 and Mcp-1 levels were also
upregulated with PCB126 exposure in the CD-fed mice (Supplementary Fig. 4). Although
we were unable to measure plasma PAI-1 levels in the MCD+PCB126 group, we anticipated
upregulated levels as well based on the hepatic PAI-1 expression in these mice.
3.2. Effects of MCD diet and PCB exposure on hepatic gene expression

Author Manuscript

Because MCD feeding induced fatty liver disease and the mice livers were further exploited
with PCB exposure, we evaluated liver function by measuring hepatic expression of genes
involved in lipid metabolism and oxidative stress. Hepatic mRNA levels of Pparα and
Cpt1a, both involved in fatty acid oxidation, were measured (Fig. 3A & B). Aroclor1260
exposure increased Pparα expression in the CD group while PCB126 decreased its
expression and this was significant in the MCD group. A similar observation was seen in
Cpt1a expression. Interestingly, the MCD diet decreased Cpt1a expression as well. Cd36, a
fatty acid translocase was also assessed and PCB126 upregulated Cd36 expression in the CD
group (Fig. 3C). However, PCB126 negatively regulated Cd36 expression in the MCD
group, indicating a significant interaction between diet and PCB126 (p=0.001). MCD diet
itself upregulated Cd36 expression, a phenomenon seen in late stage MCD feeding (Park et
al. 2011). Fas was also measured and its expression was decreased with PCB126 exposure in
both diet groups (Fig. 3D). The hepatic expression of anti-oxidative genes, Nqo1 and
Hmox-1, was also assessed (Fig. 3E & F). Exposure to PCB126 increased hepatic expression
of both Nqo1 and Hmox-1 while there was no effect with Aroclor1260 exposure. There was
a significant interaction between MCD feeding and PCB126 for increased Nqo1 expression
(p=0.002).
3.3. Cardiovascular assessment

Author Manuscript

In order to assess cardiac parameters, cardiac gene expression was evaluated. The
combination of a compromised liver and PCB exposure could hamper cardiac function as
well as induce injury on the related vasculature, hence we initially measured systolic blood
pressure in these animals. The non-invasive blood pressure measurements were performed
on week 11 of the study and hence only 5 groups were left. MCD feeding appeared to
increase blood pressure with or without Aroclor1260 exposure, indicative of hypertension in
these groups. The CD+PCB126 group had lower systolic blood pressure readings compared
to the CD mice (Fig. 4A). Cardiac expression of selected genes that play a role in heart
injury were evaluated and included the fibroblast growth factor (Fgf21, protective in cardiac
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hypertrophy) and atrial natriuretic peptide (ANF, counter high blood pressure) (Fig. 4B &
C). The cardiac expression of Fgf21 was decreased in the CD+PCB126 as well as the MCD
groups but Aroclor1260 had no effect. On the other hand, ANF expression was increased
with Aroclor1260 exposure. Additionally, plasma levels of early markers of endothelial
dysfunction namely, intracellular adhesion molecule (ICAM-1), platelet endothelial cell
adhesion molecule (Pecam-1), P-Selectin and thrombomodulin were measured (Fig. 4D–G).
Interestingly, all the plasma CVD markers were upregulated in MCD-fed mice exposed to
Aroclor 1260 and there was a significant interaction between diet and Aroclor 1260
exposure for ICAM-1 (p=0.003) and thrombomodulin (p=0.0006).
3.4. Metabolic assessment: Effects on glucose metabolism, energy expenditure and
adipokines
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The liver is also involved in maintaining carbohydrate homeostasis, hence we hypothesized
that the induced liver injury may also disrupt glucose metabolism. Therefore, glucose
tolerance, insulin resistance/sensitivity, pancreatic insulin secretion, and serum adipokines
were measured. Fasting blood glucose levels were measured prior to performing the glucose
tolerance test (Fig. 5A). The CD+PCB126 group appeared to have lower fasting blood
glucose levels versus the Aroclor1260-exposed counterparts. The glucose tolerance test
showed that the CD+PCB126 group also had improved glucose tolerance/glucose uptake
versus other groups as measured by the Area Under the Curve (AUC) (Fig. 5B). In order to
evaluate if these animals suffered from insulin resistance, we measured fasting plasma
insulin levels and calculated the HOMA-IR as an index of insulin resistance (Fig. 5C & D).
Interestingly, the MCD feeding led to decreased insulin levels which was decreased further
with Aroclor1260 exposure. In fact, these mice showed no signs of insulin resistance
(HOMA-IR) and instead demonstrated improved insulin sensitivity (QUICKI) (Fig. 5E).
There was a significant interaction between MCD feeding and Aroclor1260 on the
calculated insulin sensitivity (p=022). However, HOMA-β which is a function of pancreatic
cell function showed that both MCD and MCD+Aroclor1260 groups had lower HOMA-β
levels, indicating decreased pancreatic insulin secretion in these groups (Fig. 5F).
Furthermore, the hepatic expression of two gluconeogenic enzymes (Pepck-1) and
glucose-6-phosphatase (G6Pase) were measured (Fig. 5G & H). PCB 126 decreased hepatic
expression Pepck-1 in the CD-fed mice while both genes were downregulated in the MCDfed mice with either PCB126 or Aroclor1260 exposure.

Author Manuscript

To assess the overall energy metabolism, mice were placed in metabolic cages and various
metabolic parameters were evaluated. The MCD feeding significantly influenced energy
expenditure as well as carbohydrate and lipid utilization. Oxygen consumption (vO2) and
carbon dioxide production (vCO2) were monitored throughout the metabolic study and the
respiration exchange rate (RER, vCO2/vO2) was calculated (Supplementary Fig. 5). The
RER which is an estimate of the respiratory quotient, indicates whether the fuel source/
energy expenditure originated from carbohydrate or lipid metabolism. An RER of 0.70
suggests that fat is predominantly utilized, whereas an RER of 0.85 suggests a mix of fat and
carbohydrate as the fuel source. MCD feeding resulted in lower RER indicating that lipid
was the major fuel source for these animals. Interestingly, Aroclor1260 exposure increased
RER versus PCB126 in the CD-fed mice. The total energy expenditure (EE) was computed
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using the modified Weir equation: EE = (3.815 + 1.232 × RER) ×VO2 and MCD feeding
also lowered EE irrespective of PCB exposure. Movement/physical activity was also
assessed utilizing beam breaks in the metabolic chambers. There was no difference in
movement/physical activity during the light cycle between the groups. However PCB126
exposure increased physical activity during the dark cycle. Interestingly MCD-fed mice did
not show any compromise in physical activity despite the observed decrease in energy
expenditure. Additionally, these mice did not show a decrease in food consumption either
but the Aroclor1260-exposed mice had a higher water intake (data not shown). Aroclor1260
exposure increased total food intake in the CD-fed mice, possibly explaining the increase in
RER. Furthermore, plasma adipokines were measured to better understand the metabolicrelated factors regarding PCB exposure and MCD feeding (Supplementary Fig. 6). Plasma
leptin levels were significantly lower with MCD feeding but plasma resistin levels were not
affected. However, Aroclor1260 exposure upregulated plasma resistin levels in the CD
group.
3.5. PCB-hepatic receptor interactions

Author Manuscript

A number of studies have established PCB activation of many hepatic receptors such as the
AhR as well as other nuclear receptors (CAR, PXR). In this study, we were interested in
evaluating the effects of PCB exposure on the hepatic expression of these receptors’ target
genes. Hepatic expression of Cyp1a2, Fmo3 (AhR targets), Cyp2b10 (CAR target) and
Cyp3a11 (PXR target) were measured. PCB126 exposure induced Cyp1a2 hepatic
expression while Aroclor1260 had no effect (Fig. 6A). Additionally, MCD feeding had no
effect on Cyp1a2 hepatic expression either. Similar to Cyp1a2, PCB126 also induced Fmo3
expression irrespective of the dietary group (Fig. 6B). Intriguingly, MCD feeding itself
appeared to induce Fmo3 mRNA levels versus CD feeding. Aroclor1260 exposure but not
PCB126 upregulated Cyp2b10 expression while MCD diet had no effect whatsoever (Fig.
6C). In contrast, MCD feeding increased the basal expression of Cyp3a11 (Fig. 6D).
Aroclor1260 also induced Cyp3a11 expression but only in the MCD group (Diet ×
Aroclor1260 interaction, p=0.039). On the other hand, PCB126 appeared to have a negative
effect on the Cyp3a11 expression in MCD-fed mice (Diet × PCB126 interaction, p=0.007),
although there was no PCB126 effect in the CD group.

4. Discussion

Author Manuscript

The current study evaluated and assessed the toxicological consequences of having a
compromised liver with concomitant persistent organic pollutant exposure. It is well
documented that PCB exposure is correlated with elevated liver enzymes that are biomarkers
of liver injury (Cave et al. 2010). Moreover, it has been demonstrated that PCB exposure in
animal models led to hepatic steatosis and non-alcoholic steatohepatitis in conjunction with
a high fat diet (Wahlang et al. 2013; Wahlang et al. 2014b). Animal studies have also
demonstrated that PCB exposure can lead to endothelial cell dysfunction and vascular
inflammation (Petriello et al. 2014). Moreover, NAFLD/NASH is considered as an
independent CVD risk factor with defective heart-liver communication exacerbating CVD
(Baskin et al. 2014; Bhatia et al. 2012). Hence, in the current study, we used a NASH mouse
model to mimic an injured hepatic state and then exposed the mice to PCBs. This is more or
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less a “two-hit” theory where liver injury acts as a first hit and environmental pollutant
exposure as the second hit. We then evaluated hepatic, cardiovascular and metabolic
parameters to test our hypothesis.

Author Manuscript

It is pertinent to note that PCBs vary in structure with structure-activity relationship studies
denoting different receptor interactions between “coplanar or dioxin-like” and “non-coplanar
or phenobarbital-like” PCBs (Luthe et al. 2008). In the current study, we employed two
different sets of PCBs, one being PCB126 which is a prototypical “dioxin-like” congener
and the other being the PCB mixture, Aroclor1260. PCB126 has been identified as an
inducer of inflammation and oxidative stress that mediates its toxicity through the AhR. The
PCB mixture, Aroclor1260, is composed primarily of non-coplanar PCBs with coplanar
PCB composition approximating 1% (Wahlang et al. 2014a). Studies on PCB mixtures such
as Aroclors have focused primarily on obesity, diabetes and hepatic diseases that are mostly
attributed to PCB-nuclear receptor (CAR, PXR) interactions, indicating different
pathological outcomes than coplanar PCBs (Gray et al. 2013; Wahlang et al. 2016).
Therefore, this study is the first to evaluate PCB effects on the liver-peripheral axis, taking
into consideration the PCB planarity. Also, previous mouse studies on PCB126 were aligned
with shorter exposure time points, hence the aftermath of chronic PCB126 exposure is yet to
be evaluated.

Author Manuscript
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In our study, NASH and hepatic fibrosis were evident using ultrasound imaging after 6
weeks of feeding the MCD diet, and this was accompanied by a decrease in percent fat
composition (accompanied by decreased plasma leptin) and a concomitant increase in
percent lean tissue mass. One of the key findings was the severe toxicity of PCB126 in the
NASH group resulting in wasting and mortality during the study period. The combination of
MCD+PCB126 contributed to more severe overall toxicity than MCD+Aroclor1260,
suggesting that in a compromised liver state, PCB 126 remained a major contributor to
further liver injury/toxicity. Interestingly, the dose of PCB126 chosen for this study was
previously used in C57Bl/6 mice to induce pro-inflammatory response but not wasting
syndrome, clearly indicating that the hepatic machinery was already compromised during
the gavage period. On the contrary, PCB126 did not induce mortality in the CD-fed mice at
the given dose. Furthermore, Aroclor1260 (20 mg/kg) did not induce mortality in the NASH
group. Indeed, PCB126 and Aroclor1260 appeared to induce different pathological states in
these animals in both the CD and MCD groups. Steatohepatitis in the NASH groups was
worsened with both PCB126 and Aroclor1260 exposures (H&E staining, CAE staining,
hepatic Tnfα induction). PCB126 appeared to induce mild steatosis and inflammation in the
CD groups. PCB126 was also a stronger mediator of both hepatic and systemic
inflammation versus Aroclor1260. This discrepancy may be explained partially through
PCB-receptor activation. PCB126 is a potent AhR inducer (Cyp1a2 and Fmo3 induction) but
does not appear to interact with murine CAR and PXR while Aroclor1260 activated CAR
and to a lesser degree, PXR. Activation of the classical AhR signaling pathway induced the
AhR target gene battery involved in xenobiotic metabolism and oxidative stress (Cyp1a2,
Nqo1 and Hmox-1) while immune responses (cytokine induction) occur though the noncanonical pathway in relation with nuclear factor kappa B (NF-κB) (Vogel et al. 1997; Vogel
et al. 2014). Per contra, PXR has a reciprocal relationship with NF-κB wherein they
mutually repress each other while some observations have implied CAR basal repression
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activity on NF-κB signaling (Gerbal-Chaloin et al. 2013; Zhou et al. 2006). Therefore, CAR
and PXR may negatively impact inflammation. Because Aroclor 1260 activated CAR and
PXR, this effect on inflammation can lead to attenuation of Aroclor1260-induced toxicity.
Nonetheless, the MCD+Aroclor1260 group manifested signs of hepatic inflammation,
implicating that other mechanisms may be involved other than CAR/PXR activation.
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Although they are xenobiotic receptors, AhR, CAR and PXR are involved in endobiotic and
overall energy metabolism as well as associated with NAFLD (Lu et al. 2015; Naik et al.
2013; Wada et al. 2009). Moreover, the model focused on PCB effects on a compromised
liver, thus it was appropriate to measure hepatic expression of genes involved in lipid
metabolism. MCD feeding suppressed Cpt1a levels and appeared to have lower energy
expenditure and RER. Aroclor1260 exposure upregulated Pparα and Cpt1a expression with
no effect on Fas expression, consistent with previous findings (Wahlang et al. 2016). The
mRNA levels of these metabolic genes were drastically reduced in the MCD+PCB126 group
of mice which is a compelling observation, indicating complete breakdown of the hepatic
machinery in these mice. Interestingly, PCB126 exposure in the CD-fed mice led to
decreased Cpt1a and increased Cd36 mRNA levels implying a state of compromised lipid
oxidation and increased lipid uptake that can mechanistically explain the observed hepatic
fat accumulation in this group. In addition to hepatic effects, we also elucidated effects on
glucose metabolism. PCBs, either as individual congeners or PCB mixtures have been
shown to affect glucose uptake, insulin levels and gluconeogenic gene expression with
arbitrary reports that are dependent on the dose, congener or mixture evaluated (Gray et al.
2013; Wahlang et al. 2016). In the current study, PCB126 appeared to induce hypoglycemia
(lower fasting blood glucose and AUC levels). “Dioxin-like” PCBs have been shown to
negatively regulate the rate-limiting gluconeogenic gene, phosphoenolpyruvate
carboxykinase (Pepck-1) which may in part explain this distinct observation (Zhang et al.
2012). PCB126 had no effect on plasma insulin levels and insulin resistance/sensitivity.
MCD feeding appeared to improve insulin resistance/sensitivity which is an established
effect but paradoxical to NASH and a reported drawback of the MCD model (Imajo et al.
2013). However, Aroclor1260 exposure significantly increased insulin sensitivity in the
MCD-fed mice which was counterintuitive since this group displayed no improvement in
plasma glucose levels and displayed decreased gluconeogenic gene expression. This group
also exhibited decreased pancreatic insulin secretion and could be attributed to pancreatic
cell dysfunction that occurred with PCB exposure (Jensen et al. 2014; Zhang et al. 2015).
However more studies concerning toxicant exposure and pancreatic function are needed to
further comprehend the mechanisms associated with this phenomenon.

Author Manuscript

With regards to extra-hepatic effects, BP assessment denoted PCB126 as a hypotensive
agent in the CD mice while MCD diet feeding caused increase in systolic BP. Also, cardiac
Fgf21 expression was lower in the MCD groups. Emerging studies have implicated the
protective role of Fgf21 against cardiac hypertrophy and oxidative stress (Planavila et al.
2015; Planavila et al. 2013). However, there was no evidence of atherosclerosis. It can be
speculated that the study duration was not sufficient to observe the PCB effects on cardiac
function and the heart. Interestingly, mice with a compromised liver and exposed to
Aroclor1260 displayed signs of endothelial cell dysfunction (increased plasma ICAM-1, PSelectin and thrombomodulin). Furthermore, studies on PCB exposure and hypertension are
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scarce, with only a few epidemiologic studies showing associations between plasma PCBs
and increased risk for hypertension (Donat-Vargas et al. 2015; Park et al. 2016). Recently, a
study by our group has reported an increase in hepatic Fmo3 expression with “dioxin-like”
PCBs, thereby implicating these pollutants as risk factors for CVD (Petriello et al. 2016). To
reiterate those previous findings, Fmo3 was measured in our study and it was upregulated
with chronic PCB126 exposure. PCB126 also upregulated plasma levels and hepatic
expression of PAI-1. Elevated PAI-1 is a risk factor for thrombosis and atherosclerosis since
this serine protease inhibitor prevents breakdown of fibrin clots (Rouch et al. 2015).
Nonetheless, in this study, the effect of PCBs on CVD renders more in-depth and
mechanistic studies. Additionally, the current findings implicated that utilizing lower doses
of PCBs and prolonging the study duration may allow us to further assess extra-hepatic
endpoints such as CVD.
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Overall, PCBs either as an individual congener or a mixture of congeners worsened liver
injury induced by the MCD diet. Notably, different receptor targets were induced that led to
different toxicity outcomes, indicating dose and congener-dependent receptor activation.
This is a crucial factor considering that all types of PCBs are in the realm of the human
exposome, and therefore human exposure can result in a combination of variable outcomes.
The study evidently pointed out pollutant exposure as key mediators of inflammation and
that environment pollutants can further perturb metabolic parameters, thus ameliorating
metabolic derangements accordingly. However, the fact that MCD+PCB126 group were
euthanized at an earlier time point than the other groups is a major limitation of the study,
and poses as a confounding factor. In summary, an animal model simulating human NASH
was utilized to study effects of PCB exposure both on the hepatic and peripheral (extrahepatic) system. The results of the current study shed some light in terms of comprehending
the consequences of chronic pollutant exposure on an already compromised liver.
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aryl hydrocarbon receptor

ANF

natriuretic peptide type A
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AUC

area under the curve

BP

blood pressure

CAE

chloroacetate esterase

CAR

constitutive androstane receptor

CD

control diet

Cd36

cluster of differentiation 36

Cpt1a

carnitine palmitoyl transferase 1a

Cyp

cytochrome P450

EE

energy expenditure

Fas

fatty acid synthase

Fmo3

flavin monooxygenase 3

Fgf21

fibroblast growth factor 21

G6Pase

glucose-6-phosphatase

H&E

hematoxylin–eosin

Hmox-1

heme oxygenase 1

HOMA- β

homeostasis model assessment of β-cell function
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HOMA-IR homeostasis model assessment of insulin resistance
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ICAM-1

intracellular adhesion molecule 1

IL-6

interleukin-6

LW/BW

liver weight to body weight

MCD

methionine-choline deficient diet

Mcp-1

macrophage chemoattractant protein-1

NAFLD

non-alcoholic fatty liver disease

NASH

nonalcoholic steatohepatitis

Nqo1

(NAD(P)H dehydrogenase, quinone 1

PCBs

polychlorinated biphenyls

PCR

polymerase chain reaction

Pepck-1

phosphoenolpyruvate carboxy kinase

Ppar

peroxisome proliferator-activated receptor
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PXR

pregnane-xenobiotic receptor

QUICKI

quantitative insulin sensitivity check index

RER

respiration exchange rate

SEM

standard error mean

Timp-1

tissue inhibitor of metalloproteinase 1

Tnfα

tumor necrosis factor alpha

PAI-1

plasminogen activator inhibitor 1
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Highlights
•

Polychlorinated biphenyls (PCBs) are persistent environmental contaminants
that are associated with multiple health disorders including liver diseases,
diabetes and cardiovascular diseases.

•

PCBs comprised of over 200 congeners based on chlorine atom substitution
and exposure to different congeners can lead to different diseased outcomes.

•

The current study utilizes a fibrotic-mouse model to study the behavior of
PCBs, either as a single congener (PCB126) or a mixture of congeners
(Aroclor1260).

•

PCB exposure in mice that already have an injured or compromised liver
worsen overall inflammation and disrupted normal liver function.
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Figure 1. Effects of PCB126 and Aroclor1260 exposure on steatosis and body weight

(A) H&E staining of hepatic sections established the occurrence of hepatocellular
hypertrophy and steatosis in the MCD-fed groups. (B) Increase in body weight with time for
C57BL/6 (n=10) taken weekly from week 1–12 for all groups except for the MCD+PCB126
group where measurements were taken from week 1–8. The % increase in body weight gain
with time was calculated and the body weight at week 1 was taken as 100%. (C) Livers were
weighed at euthanasia and the liver to bodyweight ratio was calculated. % fat composition
and % lean tissue were measured at the end of the study using the EchoMRI. Values are
mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05 versus MCD diet-fed mice, † p
<0.05 versus CD-fed mice exposed to PCB126, †† p <0.05 versus CD-fed mice exposed to
Aroclor1260.
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Figure 2. PCB126 and Aroclor1260 exposure worsened steatohepatitis caused by MCD feeding
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(A) CAE staining demonstrated neutrophil infiltration in the MCD-fed groups. Hepatic
mRNA expression for (C) Tnfα and (D) PAI-1 and (E) Timp-1 were calculated. Values are
mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05 versus MCD diet-fed mice, † p
<0.05 versus CD-fed mice exposed to PCB126, †† p <0.05 versus CD-fed mice exposed to
Aroclor1260.
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Figure 3. Effects of PCB126 and Aroclor1260 on expression of hepatic genes involved in
endobiotic metabolism
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Hepatic mRNA expression for (A) Pparα, (B) Cpt1a, (C) Cd36, (D) Fas, (E) Nqo1 and (F)
Hmox-1 were measured. Values are mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05
versus MCD diet-fed mice, † p <0.05 versus CD-fed mice exposed to PCB126, †† p <0.05
versus CD-fed mice exposed to Aroclor1260.
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Figure 4. Effects of PCB126 and Aroclor1260 on blood pressure and cardiac gene expression
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(A) Systolic blood pressure was measured using a non-invasive tail-cuff system. The
measurements were performed for four sequential days on week 11 of the study. Cardiac
mRNA expression for (B) Fgf21 and (C) ANF were measured. Plasma (D) ICAM-1, (E)
Pecam-1, (F) P-Selectin and (G) thrombomodulin were measured using the MAGPIX
system. Values are mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05 versus MCD
diet-fed mice, † p <0.05 versus CD-fed mice exposed to PCB126, †† p <0.05 versus CD-fed
mice exposed to Aroclor1260.
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Figure 5. Effects of PCB126 and Aroclor1260 in glucose metabolism and insulin resistance
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(A) Fasting blood glucose levels (mg/dL) were measured and (B) glucose tolerance test was
performed. (C) Plasma insulin levels were measured using the MAGPIX system. (D)
Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. (E)
Quantitative insulin sensitivity check index (QUICKI) and (F) HOMA-β which are indices
for insulin sensitivity were calculated. Hepatic mRNA expressions for (G) Pepck-1 and (H)
G6Pase were measured. Values are mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05
versus MCD diet-fed mice, † p <0.05 versus CD-fed mice exposed to PCB126, †† p <0.05
versus CD-fed mice exposed to Aroclor1260.
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Figure 6. PCB126 and Aroclor1260 exposure altered hepatic expression of AhR, CAR and PXR
target genes

Hepatic mRNA expressions for (A) Cyp1a2 (AhR target gene), (B) Fmo3 (AhR target gene),
(C) Cyp2b10 (CAR target gene) and (D) Cyp3a11 (Pxr target gene) were measured. Values
are mean ± SEM, * p <0.05 versus CD-fed mice, # p <0.05 versus MCD diet-fed mice, † p
<0.05 versus CD-fed mice exposed to PCB126, †† p <0.05 versus CD-fed mice exposed to
Aroclor1260.
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